Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction : the modifying role of obesity
![Thumbnail](/xmlui/bitstream/handle/10234/208161/90217_DominguezMafeE_2024.pdf.jpg?sequence=5&isAllowed=y)
Ver/ Abrir
Impacto
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction : the modifying role of obesityAutoría
Fecha de publicación
2024-06-12Editor
Elsevier ScienceDirectISSN
1871-403X; 1878-0318Cita bibliográfica
Palau, P., Núñez, G., de la Espriella, R., Miñana, G., Domínguez, E., Lorenzo, M., Lopez, L., Flor, C., Marin, P., Bayés, A., Sanchis J. & Núñez, J. (2024). Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity. Obesity Research & Clinical Practice.Tipo de documento
info:eu-repo/semantics/articleVersión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
This study investigates the association between maximal functional capacity (peakVO2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection ... [+]
This study investigates the association between maximal functional capacity (peakVO2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection fraction (HFpEF), focusing on patients with obesity. Across all participants, NT-proBNP inversely correlated with peakVO2. However, this association varied based on obesity status. In patients without obesity, there was an inverse relationship between NT-proBNP and peakVO2, while no significant correlation was observed in patients with obesity. These findings suggest that in stable ambulatory HFpEF, NT-proBNP did not predict peakVO2 in patients with obesity. [-]
Publicado en
Obesity Research & Clinical Practice, Vol. 18, Issue 3 (May-June 2024)Entidad financiadora
Ministerio de Economía y Competitividad / Instituto de Salud Carlos III | European Regional Development Fund (ERDF)
Código del proyecto o subvención
PI17/01426 | 16/11/00420 | 16/11/00403
Derechos de acceso
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [667]